Shane Olwill

Insider Reports History

Entity
Individual
Location
C/O Pieris Pharmaceuticals, Inc., 255 State Street, 9 Th Floor, Boston, MA
Signature
/s/ Ahmed Mousa, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shane Olwill:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PIERIS PHARMACEUTICALS, INC. Chief Development Officer Stock Option (Right to buy) 249K Feb 24, 2023 Direct

Insider Reports Filed by Shane Olwill

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PIRS PIERIS PHARMACEUTICALS, INC. Feb 24, 2023 1 $0 4 Feb 28, 2023 Chief Development Officer
PIRS PIERIS PHARMACEUTICALS, INC. Feb 22, 2022 1 $0 4 Feb 24, 2022 Chief Development Officer
PIRS PIERIS PHARMACEUTICALS, INC. Aug 30, 2021 4 -$138K 4 Sep 1, 2021 Chief Development Officer
PIRS PIERIS PHARMACEUTICALS, INC. Aug 1, 2021 0 $0 3 Aug 3, 2021 Chief Development Officer